These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2955085)

  • 1. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of renal function with technetium-99m MAG3.
    Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
    J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
    Lee HB; Blaufox MD
    J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
    Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
    J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
    Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
    J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of the four isomers of 99mTc-cysteinyltriglycine, an amino substituted derivative of 99mTc-MAG3.
    Cleynhens B; Adriaens P; Boonen C; Vanbilloen H; Van Nerom C; Verbruggen AM
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):69-74. PubMed ID: 7632771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimate of relative function and transit time in renographic studies.
    González A; Ros D; Pavia J
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference in clearance between kit-prepared technetium-99m-MAG3 and radioiodinated hippuric acid.
    Bubeck B; Brandau W
    J Nucl Med; 1991 Aug; 32(8):1642-4. PubMed ID: 1831230
    [No Abstract]   [Full Text] [Related]  

  • 18. 99mTc renal tubular function agents: current status.
    Eshima D; Fritzberg AR; Taylor A
    Semin Nucl Med; 1990 Jan; 20(1):28-40. PubMed ID: 2136959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of renal function using MAG3.
    Russell CD; Dubovsky EV
    J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.
    Kim CK; Stritzke P; Goldsmith SJ
    J Nucl Med; 1988 Nov; 29(11):1878-9. PubMed ID: 2972816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.